Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2018, Article ID 1983421, 8 pages
https://doi.org/10.1155/2018/1983421
Research Article

Elevated Serum Levels of Mixed Lineage Kinase Domain-Like Protein Predict Survival of Patients during Intensive Care Unit Treatment

1Department of Medicine III, University Hospital Aachen, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany
2Division of GI and Hepatobiliary Oncology, University Hospital Aachen, RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany
3Department of Internal Medicine III, University of Kiel, Rosalind-Franklin-Str. 12, 24105 Kiel, Germany

Correspondence should be addressed to Tom Luedde; ed.nehcaaku@eddeult

Received 3 November 2017; Accepted 25 December 2017; Published 11 February 2018

Academic Editor: Juan Bueno

Copyright © 2018 Mihael Vucur et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Jorgensen, M. Rayamajhi, and E. A. Miao, “Programmed cell death as a defence against infection,” Nature Reviews Immunology, vol. 17, no. 3, pp. 151–164, 2017. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Galluzzi, O. Kepp, F. K. Chan, and G. Kroemer, “Necroptosis: mechanisms and relevance to disease,” Annual Review of Pathology, vol. 12, no. 1, pp. 103–130, 2017. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Gautheron, M. Vucur, A. T. Schneider et al., “The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance,” Nature Communications, vol. 7, article 11869, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Gautheron, M. Vucur, F. Reisinger et al., “A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis,” EMBO Molecular Medicine, vol. 6, no. 8, pp. 1062–1074, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Vucur, F. Reisinger, J. Gautheron et al., “RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation,” Cell Reports, vol. 4, no. 4, pp. 776–790, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Luedde, M. Lutz, N. Carter et al., “RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction,” Cardiovascular Research, vol. 103, no. 2, pp. 206–216, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Murphy, P. E. Czabotar, J. M. Hildebrand et al., “The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism,” Immunity, vol. 39, no. 3, pp. 443–453, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Sun, H. Wang, Z. Wang et al., “Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase,” Cell, vol. 148, no. 1-2, pp. 213–227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Linkermann and D. R. Green, “Necroptosis,” The New England Journal of Medicine, vol. 370, no. 5, pp. 455–465, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Kaczmarek, P. Vandenabeele, and D. V. Krysko, “Necroptosis: the release of damage-associated molecular patterns and its physiological relevance,” Immunity, vol. 38, no. 2, pp. 209–223, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Ahn and A. Prince, “Participation of necroptosis in the host response to acute bacterial pneumonia,” Journal of Innate Immunity, vol. 9, no. 3, pp. 262–270, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Kitur, S. Wachtel, A. Brown et al., “Necroptosis promotes Staphylococcus aureus clearance by inhibiting excessive inflammatory signaling,” Cell Reports, vol. 16, no. 8, pp. 2219–2230, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Roderburg, F. Benz, D. V. Cardenas et al., “Persistently elevated osteopontin serum levels predict mortality in critically ill patients,” Critical Care, vol. 19, no. 1, p. 271, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Singer, C. S. Deutschman, C. W. Seymour et al., “The third international consensus definitions for sepsis and septic shock (Sepsis-3),” JAMA, vol. 315, no. 8, pp. 801–810, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Tacke, C. Roderburg, F. Benz et al., “Levels of circulating miR-133a are elevated in sepsis and predict mortality in critically ill patients,” Critical Care Medicine, vol. 42, no. 5, pp. 1096–1104, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Koch, E. Sanson, A. Helm, S. Voigt, C. Trautwein, and F. Tacke, “Regulation and prognostic relevance of serum ghrelin concentrations in critical illness and sepsis,” Critical Care, vol. 14, no. 3, p. R94, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Koch, O. A. Gressner, E. Sanson, F. Tacke, and C. Trautwein, “Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients,” Critical Care, vol. 13, no. 3, p. R95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Roderburg, G. W. Urban, K. Bettermann et al., “Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis,” Hepatology, vol. 53, no. 1, pp. 209–218, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Benz, C. Roderburg, D. Vargas Cardenas et al., “U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis,” Experimental & Molecular Medicine, vol. 45, no. 9, article e42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Roderburg, F. Benz, D. Vargas Cardenas et al., “Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases,” Liver International, vol. 35, no. 4, pp. 1172–1184, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. M. B. Afonso, P. M. Rodrigues, T. Carvalho et al., “Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis,” Clinical Science, vol. 129, no. 8, pp. 721–739, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. W. J. Youden, “Index for rating diagnostic tests,” Cancer, vol. 3, no. 1, pp. 32–35, 1950. View at Publisher · View at Google Scholar
  23. A. Koch, S. Voigt, C. Kruschinski et al., “Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients,” Critical Care, vol. 15, no. 1, p. R63, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Duprez, N. Takahashi, F. van Hauwermeiren et al., “RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome,” Immunity, vol. 35, no. 6, pp. 908–918, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Sharma, S. Matsuo, W. L. Yang, Z. Wang, and P. Wang, “Receptor-interacting protein kinase 3 deficiency inhibits immune cell infiltration and attenuates organ injury in sepsis,” Critical Care, vol. 18, no. 4, p. R142, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. D. J. Moore, A. Greystoke, F. Butt et al., “A pilot study assessing the prognostic value of CK18 and nDNA biomarkers in severe sepsis patients,” Clinical Drug Investigation, vol. 32, no. 3, pp. 179–187, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Yoon, A. Kovalenko, K. Bogdanov, and D. Wallach, “MLKL, the protein that mediates necroptosis, also regulates endosomal trafficking and extracellular vesicle generation,” Immunity, vol. 47, no. 1, pp. 51–65.e7, 2017. View at Publisher · View at Google Scholar
  28. P. Strnad, F. Tacke, A. Koch, and C. Trautwein, “Liver—guardian, modifier and target of sepsis,” Nature Reviews Gastroenterology & Hepatology, vol. 14, no. 1, pp. 55–66, 2017. View at Publisher · View at Google Scholar · View at Scopus
  29. D. F. Gaieski, M. E. Mikkelsen, R. A. Band et al., “Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department,” Critical Care Medicine, vol. 38, no. 4, pp. 1045–1053, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Harker, S. Carville, R. Henderson, H. Gray, and on behalf of the Guideline Development Group, “Key recommendations and evidence from the NICE guideline for the acute management of ST-segment-elevation myocardial infarction,” Heart, vol. 100, no. 7, pp. 536–543, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Roderburg, F. Benz, F. Schüller et al., “Serum levels of TNF receptor ligands are dysregulated in sepsis and predict mortality in critically ill patients,” PLoS One, vol. 11, no. 4, article e0153765, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. L. P. Bechmann, C. Jochum, P. Kocabayoglu et al., “Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury,” Journal of Hepatology, vol. 53, no. 4, pp. 639–647, 2010. View at Publisher · View at Google Scholar · View at Scopus